FTC Continues To Target 'Junk' Drug Patents
By Adam Lidgett · April 30, 2024, 7:15 PM EDT
Federal trade officials told a series of pharmaceutical companies — including the makers of the controversial diabetes and weight loss drug Ozempic — that they may have listed faulty patents in...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login